Swedish Orphan Biovitrum AB (publ)
Sector
Location
Market Cap
USD 10.27 B
Share Price
USD 29.53
Avg Daily Volume
337,805
Change (1 day)
Change (1 year)
Change (YTD)
AbbVie Inc.
USD 190.28
ABBV
Novo Nordisk A/S
USD 70.93
NOVO-B.CO
Roche Holding AG
USD 345.06
RO.SW
Novartis AG
USD 116.76
NOVN.SW
AstraZeneca PLC
USD 145.14
AZN.L
Abbott Laboratories
USD 126.54
ABT
Merck & Co., Inc.
USD 84.71
MRK
Amgen Inc.
USD 306.58
AMGN
Pfizer Inc.
USD 24.79
PFE
Gilead Sciences, Inc.
USD 116.20
GILD
Sanofi
USD 99.93
SAN.PA
Vertex Pharmaceuticals Incorporated
USD 469.65
VRTX
Bristol-Myers Squibb Company
USD 48.43
BMY
CSL Limited
USD 175.87
CSL.AX
Chugai Pharmaceutical Co., Ltd.
USD 49.71
4519.T
Date | EPS (Diluted) | Shares (Diluted, Weighted) | Selling, General, and Administrative Expenses (SG&A) | Research and Development (R&D) Expenses |
---|
AbbVie Inc.
USD 190.28
ABBV
Novo Nordisk A/S
USD 70.93
NOVO-B.CO
Roche Holding AG
USD 345.06
RO.SW
Novartis AG
USD 116.76
NOVN.SW
AstraZeneca PLC
USD 145.14
AZN.L
Abbott Laboratories
USD 126.54
ABT
Merck & Co., Inc.
USD 84.71
MRK
Amgen Inc.
USD 306.58
AMGN
Pfizer Inc.
USD 24.79
PFE
Gilead Sciences, Inc.
USD 116.20
GILD
Sanofi
USD 99.93
SAN.PA
Vertex Pharmaceuticals Incorporated
USD 469.65
VRTX
Bristol-Myers Squibb Company
USD 48.43
BMY
CSL Limited
USD 175.87
CSL.AX
Chugai Pharmaceutical Co., Ltd.
USD 49.71
4519.T